Holen Sie sich die Stockscreener-App
1.85
2.78%
0.05
Finanzdaten der Acumen Pharmaceuticals Inc-Aktie (ABOS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
3.85%
17.77
|
18.49 | 16.04 | 13.48 | 13.13 |
| Interest Income/Expense |
1.00
|
- | - | - | - |
| Operating Income/Loss |
3.85%
-17.77
|
-18.49 | -16.04 | -13.48 | -13.13 |
| Nonoperating Income/Loss |
45.85%
2.901
|
1.989 | 3.082 | 1.868 | 1.828 |
| Income/Loss From Continuing Operations Before Tax |
9.84%
-14.87
|
-16.50 | -12.96 | -11.61 | -11.31 |
| Income/Loss From Continuing Operations After Tax |
9.84%
-14.87
|
-16.50 | -12.96 | -11.61 | -11.31 |
|
Net Income/Loss
|
9.84%
-14.87
|
-16.50 | -12.96 | -11.61 | -11.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,808%
59.81
|
3.1344 | 54.23 | 41.03 | 41.03 |
| Diluted Average Shares |
1,808%
59.81
|
3.1344 | 54.23 | 41.03 | 41.03 |
| Basic Earnings Per Share |
13.79%
-0.25
|
-0.29 | -0.24 | -0.28 | -0.28 |
| Diluted Earnings Per Share |
13.79%
-0.25
|
-0.29 | -0.24 | -0.28 | -0.28 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):